CClinicalTrials.gg
Status unknownNCT02693639Updated Feb 29, 2016

Prediction Value of PANX1 in Infection Post Liver Transplantation

An observational study in Infection, sponsored by Lin Zhong. Status unknown. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-02-29.

Sponsored by Lin Zhong · Observational

The sponsor has not verified this record recently (last verified Feb 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine prediction value of PANX1 expression in infection post liver transplantation.

02

Conditions studied

  • Infection

Browse trials for

Keywords

  • PANX1
  • Infection
  • Liver transplantation
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's planned enrollment of 200 is below the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Lin Zhong is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients underwent liver transplantation.

Inclusion criteria

  • patients underwent liver transplantation.

Exclusion criteria

Exclusion Criteria:

  • re-transplantation
  • multiorgan transplantation
  • living donors or split-liver donors liver transplantation
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • liver transplantation grafts
06

What researchers measure

Primary outcomes

  1. Post-transplant infections

    Frequency of clinically or microbiologically documented infection after transplantation.

    Time frame: 90 days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 29, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02693639
Lead sponsor
Lin Zhong
Collaborators
Chinese Academy of Sciences
Responsible party
Lin Zhong (Director of department of liver transplantation, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine) — Sponsor-investigator
First posted
Feb 29, 2016
Start date
Feb 2016
Primary completion
Feb 2020 (estimated)
Completion
Feb 2020 (estimated)
Last update
Feb 29, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion